▽ Strontium ranelate discontinued

▼ Strontium ranelate discontinued The maker of strontium ranelate (Protelos/Osseor), Les Laboratoires Servier, will cease the distribution of the drug in August 2017. ¹ Strontium ranelate was granted marketing authorisation in 2004 for the treatment of severe osteoporosis in postmenopausal women and adult men who are at high risk of fracture, for whom treatment with other medicinal products approved for the treatment of osteoporosis is not possible. ² The National Institute for Health and Care Excellence guidelines include it as an alternative option for the primary and secondary prevention of osteoporotic...